Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Barclays upgrades Wizz Air, says Abu Dhabi exit is a 'strategic positive'

(Sharecast News) - Barclays upgraded Wizz Air on Thursday to 'equalweight' from 'underweight' and lifted the price target to 1,100p from 900p as it said the decision to exit Abu Dhabi was a "strategic positive". "We think it is a very positive move by Wizz to exit its Abu Dhabi operations," the bank said.

"We have been consistently sceptical of Wizz's Mid-east expansion, seeing Wizz disadvantaged in accessing key traffic rights."

It noted that the business has lost around €40m over the past two years and said it sees little hope of this improving, given regulatory constraints.

"The company also highlights geopolitical instability and the challenges of the hot harsh climate on engines," Barclays said.

"Whilst these were clearly relevant, we would be surprised if these challenges were unexpected.

"The move looks to us to be a welcome recognition of where Wizz can compete successfully (CEE) and where it has fewer strategic advantages."

Looking forward, Barclays said the key change that it would like to see from Wizz is a significant cut to its growth plans from around 20% per annum to single-digit growth rates.

The bank said it thinks that Wizz was driven to open the Abu Dhabi base specifically because it had more aircraft than it could sensibly deploy in its strategic strength market.

"If Wizz can reduce its growth plan to a modest single-digit growth rate, then we see it being able to leverage its strong market position in CEE successfully," it said.

"We also would like to see Wizz cancel its orders for the A321XLR aircraft, which is not in our view well suited for LCC operations. We expect flag carriers to successfully use this aircraft, with premium seating and some cargo revenues."

At 1240 BST, the shares were up 0.7% at 1,026p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.